Evidence map›Paper›PMID 31296356›Full record

ArticleJournal of autoimmunity2019

Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity.

Ameya S Gokhale, Arunakumar Gangaplara, Maria Lopez-Occasio, Angela M Thornton, Ethan M Shevach

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of autoimmunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Aiolos and Eos drive distinct human TH17 functional states.Cellular and molecular life sciences : CMLS · 2026
    Article
  3. Article
  4. CD25Frontiers in immunology · 2026
    Article
  5. IKZF-associated inborn errors of immunity.Journal of human immunity · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Long noncoding RNA LIRIL2R modulates FOXP3 levels and suppressive function of human CD4Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.Advances in experimental medicine and biology · 2024
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ameya S GokhaleLaboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Arunakumar GangaplaraLaboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Maria Lopez-OccasioLaboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Angela M ThorntonLaboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Ethan M ShevachLaboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. Electronic address: eshevach@niaid.nih.gov.
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Studies of the Function of Naturally Occurring and Adaptive T Regulatory CellsZIAAI000959 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHEVACH, ETHAN · 2009 to 2025
$17.6M
RECEPTORS, CORECEPTORS, AND COUNTER RECEPTORS IN T CELL ACTIVATIONZ01AI000224 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI SHEVACH, ETHAN M. · 1985 to 2008
$3.5M
Intramural NIH HHS Z01 AI000224
6 · The paper itself

Abstract

Eos (lkzf4) is a member of the Ikaros family of transcription factors and is preferentially expressed in T-regulatory (Treg) cells. However, the role of Eos in Treg function is controversial. One study using siRNA knock down of Eos demonstrated that it was critical for Treg suppressor function. In contrast, Treg from mice with a global deficiency of Eos had normal Treg function in vitro and in vivo. To further dissect the function of Eos in Tregs, we generated mice with a conditional knock out of Eos in Treg cells (lkzf4

Indexed as

AnimalsAutoimmunityCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCell Line, TumorDNA-Binding ProteinsEncephalomyelitis, Autoimmune, ExperimentalFemaleForkhead Transcription FactorsInflammatory Bowel DiseasesMaleMiceMice, Inbred C57BLMice, KnockoutMyelin-Oligodendrocyte GlycoproteinDNA-Binding ProteinsForkhead Transcription FactorsMyelin-Oligodendrocyte GlycoproteinNerve Tissue ProteinsZfpn1a4 protein, mouseEAEEosFoxp3T effector cellsTranscription factorT regulatory cells

Identifiers

PMID31296356
PMCPMC11046398
OpenAlexW2958944529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.